Cafestol has a weaker inhibitory effect on osteoclastogenesis than kahweol and promotes osteoblast differentiation

Yutaka Fukuma, Eiko Sakai, Kazuhisa Nishishita, Kuniaki Okamoto, Takayuki Tsukuba

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Bone homeostasis is regulated by a balance between osteoclast (OCL)-mediated bone resorption and osteoblast (OBL)-mediated bone formation. Thus, developing a compound that simultaneously inhibits OCL function and promotes OBL function would be useful as a new medical therapy for bone diseases. Here, we examined the effects of cafestol, a coffee diterpene, on the differentiation of OCLs and OBLs. Cafestol prevented OCL formation in a dose-dependent manner and suppressed the bone-resorbing activity of OCLs. Interestingly, the viability of OCLs treated with 10-50 μM cafestol was significantly higher than that of untreated cells. At the molecular level, cafestol markedly decreased RANKL-induced phosphorylation of extracellular signal-regulated kinase (Erk) and inhibitor of nuclear factor kappa B alpha (IκBα). Compared to kahweol, another coffee-specific diterpene, the inhibitory effects of cafestol were milder on OCL differentiation, and cafestol and kahweol showed different characteristics in induction of the phase ΙΙ antioxidant enzymes and sensitivities in nuclear factor-erythroid 2-related factor 2 (Nrf2)-deficient BMMs. In addition to inhibiting OCLs, cafestol enhanced the differentiation of osteoblastic cells by increasing the mRNA levels of differentiation markers. Thus, cafestol inhibits OCL differentiation and promotes OBL differentiation, suggesting that cafestol may be a novel agent for bone diseases.

Original languageEnglish
Pages (from-to)222-231
Number of pages10
JournalBioFactors
Volume41
Issue number4
DOIs
Publication statusPublished - Jul 1 2015
Externally publishedYes

Fingerprint

Osteoblasts
Osteogenesis
Osteoclasts
Bone
Coffee
Diterpenes
Bone Diseases
cafestol
kahweol
Phosphorylation
NF-kappa B
Differentiation Antigens
Extracellular Signal-Regulated MAP Kinases
Bone Resorption
Cell Differentiation
Homeostasis
Antioxidants
Cells
Bone and Bones
Messenger RNA

Keywords

  • Bone resorption
  • Cafestol
  • Kahweol
  • Osteoblast
  • Osteoclast

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Clinical Biochemistry

Cite this

Cafestol has a weaker inhibitory effect on osteoclastogenesis than kahweol and promotes osteoblast differentiation. / Fukuma, Yutaka; Sakai, Eiko; Nishishita, Kazuhisa; Okamoto, Kuniaki; Tsukuba, Takayuki.

In: BioFactors, Vol. 41, No. 4, 01.07.2015, p. 222-231.

Research output: Contribution to journalArticle

Fukuma, Yutaka ; Sakai, Eiko ; Nishishita, Kazuhisa ; Okamoto, Kuniaki ; Tsukuba, Takayuki. / Cafestol has a weaker inhibitory effect on osteoclastogenesis than kahweol and promotes osteoblast differentiation. In: BioFactors. 2015 ; Vol. 41, No. 4. pp. 222-231.
@article{a2c0cc9bd0694b51934af696e17013df,
title = "Cafestol has a weaker inhibitory effect on osteoclastogenesis than kahweol and promotes osteoblast differentiation",
abstract = "Bone homeostasis is regulated by a balance between osteoclast (OCL)-mediated bone resorption and osteoblast (OBL)-mediated bone formation. Thus, developing a compound that simultaneously inhibits OCL function and promotes OBL function would be useful as a new medical therapy for bone diseases. Here, we examined the effects of cafestol, a coffee diterpene, on the differentiation of OCLs and OBLs. Cafestol prevented OCL formation in a dose-dependent manner and suppressed the bone-resorbing activity of OCLs. Interestingly, the viability of OCLs treated with 10-50 μM cafestol was significantly higher than that of untreated cells. At the molecular level, cafestol markedly decreased RANKL-induced phosphorylation of extracellular signal-regulated kinase (Erk) and inhibitor of nuclear factor kappa B alpha (IκBα). Compared to kahweol, another coffee-specific diterpene, the inhibitory effects of cafestol were milder on OCL differentiation, and cafestol and kahweol showed different characteristics in induction of the phase ΙΙ antioxidant enzymes and sensitivities in nuclear factor-erythroid 2-related factor 2 (Nrf2)-deficient BMMs. In addition to inhibiting OCLs, cafestol enhanced the differentiation of osteoblastic cells by increasing the mRNA levels of differentiation markers. Thus, cafestol inhibits OCL differentiation and promotes OBL differentiation, suggesting that cafestol may be a novel agent for bone diseases.",
keywords = "Bone resorption, Cafestol, Kahweol, Osteoblast, Osteoclast",
author = "Yutaka Fukuma and Eiko Sakai and Kazuhisa Nishishita and Kuniaki Okamoto and Takayuki Tsukuba",
year = "2015",
month = "7",
day = "1",
doi = "10.1002/biof.1218",
language = "English",
volume = "41",
pages = "222--231",
journal = "BioFactors",
issn = "0951-6433",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Cafestol has a weaker inhibitory effect on osteoclastogenesis than kahweol and promotes osteoblast differentiation

AU - Fukuma, Yutaka

AU - Sakai, Eiko

AU - Nishishita, Kazuhisa

AU - Okamoto, Kuniaki

AU - Tsukuba, Takayuki

PY - 2015/7/1

Y1 - 2015/7/1

N2 - Bone homeostasis is regulated by a balance between osteoclast (OCL)-mediated bone resorption and osteoblast (OBL)-mediated bone formation. Thus, developing a compound that simultaneously inhibits OCL function and promotes OBL function would be useful as a new medical therapy for bone diseases. Here, we examined the effects of cafestol, a coffee diterpene, on the differentiation of OCLs and OBLs. Cafestol prevented OCL formation in a dose-dependent manner and suppressed the bone-resorbing activity of OCLs. Interestingly, the viability of OCLs treated with 10-50 μM cafestol was significantly higher than that of untreated cells. At the molecular level, cafestol markedly decreased RANKL-induced phosphorylation of extracellular signal-regulated kinase (Erk) and inhibitor of nuclear factor kappa B alpha (IκBα). Compared to kahweol, another coffee-specific diterpene, the inhibitory effects of cafestol were milder on OCL differentiation, and cafestol and kahweol showed different characteristics in induction of the phase ΙΙ antioxidant enzymes and sensitivities in nuclear factor-erythroid 2-related factor 2 (Nrf2)-deficient BMMs. In addition to inhibiting OCLs, cafestol enhanced the differentiation of osteoblastic cells by increasing the mRNA levels of differentiation markers. Thus, cafestol inhibits OCL differentiation and promotes OBL differentiation, suggesting that cafestol may be a novel agent for bone diseases.

AB - Bone homeostasis is regulated by a balance between osteoclast (OCL)-mediated bone resorption and osteoblast (OBL)-mediated bone formation. Thus, developing a compound that simultaneously inhibits OCL function and promotes OBL function would be useful as a new medical therapy for bone diseases. Here, we examined the effects of cafestol, a coffee diterpene, on the differentiation of OCLs and OBLs. Cafestol prevented OCL formation in a dose-dependent manner and suppressed the bone-resorbing activity of OCLs. Interestingly, the viability of OCLs treated with 10-50 μM cafestol was significantly higher than that of untreated cells. At the molecular level, cafestol markedly decreased RANKL-induced phosphorylation of extracellular signal-regulated kinase (Erk) and inhibitor of nuclear factor kappa B alpha (IκBα). Compared to kahweol, another coffee-specific diterpene, the inhibitory effects of cafestol were milder on OCL differentiation, and cafestol and kahweol showed different characteristics in induction of the phase ΙΙ antioxidant enzymes and sensitivities in nuclear factor-erythroid 2-related factor 2 (Nrf2)-deficient BMMs. In addition to inhibiting OCLs, cafestol enhanced the differentiation of osteoblastic cells by increasing the mRNA levels of differentiation markers. Thus, cafestol inhibits OCL differentiation and promotes OBL differentiation, suggesting that cafestol may be a novel agent for bone diseases.

KW - Bone resorption

KW - Cafestol

KW - Kahweol

KW - Osteoblast

KW - Osteoclast

UR - http://www.scopus.com/inward/record.url?scp=84939570779&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84939570779&partnerID=8YFLogxK

U2 - 10.1002/biof.1218

DO - 10.1002/biof.1218

M3 - Article

C2 - 26154488

AN - SCOPUS:84939570779

VL - 41

SP - 222

EP - 231

JO - BioFactors

JF - BioFactors

SN - 0951-6433

IS - 4

ER -